GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
Sample GSM1586368 Query DataSets for GSM1586368
Status Public on Apr 01, 2015
Title siCtrl8T
Sample type SRA
Source name siRNA control, batch 8N
Organism Mus musculus
Characteristics cell line: C2C12
treatment time: 32 hr
kd batch id: 8T
Treatment protocol Differentiated C2C12 cell samples in this study are those harvested four days after differentiation. Transfection with siRNAs was carried out by Lipofectamine™ 2000 (Invitrogen) according to manufacturer’s recommendations. Transfection was carried out for 48 hr or 32 hr. The U1D oligo (5'-gCcAgGuAaGuau) and mutant U1D (mU1D) oligo (5'-gCcAgGcAcGuau), where locked nucleic acid (LNA) residues are in uppercase and 2’-OMe RNA bases are in lowercase, were previously described in Goraczniak et al. (Goraczniak et al., 2009). These oligos were transfected into C2C12 cells at 35 μM using Lipofectamine 2000 when the confluency of cells was about 50%. Cells were harvested 8 hr or 24 hr after transfection.
Growth protocol C2C12 cells were maintained in Dulbecco's Modified Eagles Medium (DMEM) supplemented with 10% fetal bovine serum (FBS). Differentiation of C2C12 cells was induced by switching cell media to DMEM+ 2% horse serum (Sigma) when cells were ~100% confluent. All media were also supplemented with 100 units/ml penicillin and 100 μg/ml streptomycin.
Extracted molecule total RNA
Extraction protocol For nuclear RNA extraction, cells collected by a scrapper were suspended in cell lysis buffer (10 mM Tris pH 7.4, 10 mM NaCl, 0.5% NP40, 1 mM DTT), followed by vortexing for 10 sec and incubation on ice for 10 min. After centrifugation of the lysate at 500 x g for 5 min at 4oC, the pellet was re-suspended in the cell lysis buffer for nuclear RNA extraction. Both total and nuclear RNAs were extracted using Trizol (Invitrogen) according to manufacturer's protocol. RNA quality was analyzed in an Agilent Bioanalyzer using the RNA pico600 kit before processing for deep sequencing.
The 3’READS method used in this study was previously described (Hoque et al., 2014). Briefly, 25 μg of total RNA was used for each sample, and poly(A)+ RNA was selected using oligo d(T)25 magnetic beads (NEB), followed by on-bead fragmentation using RNase III (NEB). Poly(A)+ RNA fragments were then selected using the chimeric U5 and T45 (CU5T45) oligo conjugated on streptavidin beads, followed by RNase H digestion (NEB). Eluted RNA fragments were ligated with 5’ and 3’ adapters, followed by RT and PCR (15x) to obtain cDNA libraries for sequencing on the Illumina platform.
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model Illumina HiSeq 2500
Data processing The details of the method was described previously (Hoque, et al., 2014). Briefly, the 3'-adapter sequence was first removed (using fastx_clipper -a TGGAATT). Reads were mapped to the mouse genome (mm9) using Bowtie2 (local mode). 5' four random nucleotides were removed before mapping using "-5 4" parameter in bowtie2. Reads with a mapping quality score (MAPQ) ≥10 were selected for further analysis. Reads with ≥2 non-genomic As after alignment were called polyA site supporting (PASS) reads.
All PASS reads mapped to the 3’-most exons of a gene were used to calculate the expression level of the gene, shown as the reads per million total PASS reads (RPM) value.
Genome_build: mm9
Supplementary_files_format_and_content: tab delimited file containing information of gene symbol, pA coordinates, read number of pAs in different samples
Submission date Jan 16, 2015
Last update date May 15, 2019
Contact name Wencheng Li
Organization name PTC Therapeutics
Street address 100 Corporate Count
City South Plainfield
State/province NJ - New Jersey
ZIP/Postal code 07080
Country USA
Platform ID GPL17021
Series (1)
GSE62001 Regulation of alternative cleavage and polyadenylation by 3’ end processing and splicing factors
BioSample SAMN03286971
SRA SRX845828

Supplementary data files not provided
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap